On August 4, 2020 Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, reported that the company will participate in two upcoming investor conferences in August (Press release, Ascendis Pharma, AUG 4, 2020, View Source [SID1234562767]). Company executives will provide a business overview and update on the company’s pipeline programs.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details

Event 2020 Wedbush PacGrow Healthcare Virtual Conference
Location Virtual
Date Tuesday, August 11, 2020
Time 2:20 p.m. Eastern Time

Event Canaccord Genuity 40th Annual Growth Conference
Location Virtual
Date Wednesday, August 12, 2020
Time 1:30 p.m. Eastern Time
A live webcast of the presentations will be available in the Investors and News section of the Ascendis Pharma website at www.ascendispharma.com. A webcast replay will also be available on this website shortly after conclusion of the events for 30 days.